DAFNA Capital Management »

Nervgen Pharma Ord shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 1.1M 2.06

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Rock Springs Capital Management
DAFNA Capital Management
Ghisallo Capital Management
Armistice Capital
LMR Partners
Stonepine Capital Management
Marshall Wace
UBS Group
Jane Street
Woodline Partners
PFG Investments
Susquehanna International
Bank of America Corporation
Royal Bank of Canada

View all funds holding Nervgen Pharma Ord